Brief: Lavipharm repays its 2 USA-based units' debt of EUR 27.3 mln
Feb 12 (Reuters) - Lavipharm SA LPHr.AT :
* Transfers all assets of Lavipharm Laboratories INC to Thallium Holding Company to repay
its 2 USA-based units' debt
* Transaction will significantly affect positively the consolidated results of 2016 Q1
* Value of assets of unit Lavipharm Laboratories INC is 27.3 million euros ($30.64 million)
Source text: http://bit.ly/1mwPHTa
Further company coverage: LPHr.AT
($1 = 0.8910 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 6983920;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY